Skip to main content

Top 10 Medical Device Technologies Which Booming in 2019

The global top 10 medical device technologies market is expected to reach USD 428.97 Billion by 2020, at a CAGR of 5.5% from 2015 to 2020. Growth in the global top 10 medical device technologies market is mainly driven by factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years (DALYs), technological advancements in medical devices, and growing aging population. Moreover, increasing investments from government bodies and private players in healthcare sectors in emerging economies and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and excise tax on medical devices in the U.S. are restraining the growth of the market.

Top 10 Medical Device Technologies (2)

The top 10 medical device technologies market studied in this report is mainly segmented by types and region. Based on type, the top 10 medical device technologies market is segmented into in vitro diagnostics (IVD) devices, cardiology devices, diagnostic imaging devices, orthopedic devices, ophthalmology devices, endoscopy devices, diabetes care devices, wound management devices, kidney/dialysis devices, and anesthesia & respiratory care devices. The IVD devices segment accounted for the largest share of approximately 17.1% of the top 10 medical device technologies market, owing to the increase in the prevalence of diabetes, cardiovascular diseases, and cancer.

Download FREE Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96

Geographically, North America dominated the global top 10 medical device technologies market, with a share of 39.7% in 2014. The large share of this region can be attributed to greater accessibility to advanced technologies, improved healthcare infrastructure, established distribution channels, and the presence of a large number of leading market players such as Johnson & Johnson (U.S.), Siemens Healthcare (Germany), Medtronic (U.S.), Abbott Laboratories Inc. (U.S.), and Stryker Corporation (U.S.). However, the Asia-Pacific region is expected to be the fastest-growing top 10 medical device technologies market during the forecast period. Large population and rising healthcare needs, increased spending capabilities of consumers on healthcare, improving healthcare infrastructure in the region, and increasing investments by leading players and respective government agencies in the region are contributing to the growth of the APAC top 10 medical device technologies market during the forecast period.

The global top 10 medical device technologies market is fragmented and highly competitive. The key players in this market are Johnson & Johnson (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Medtronic (U.S.), Philips Healthcare (Netherlands), Roche Diagnostics (Switzerland), Abbott Laboratories Inc. (U.S.), Smith & Nephew plc (U.K.), Stryker Corporation (U.S.), and Boston Scientific Corporation (U.S.).

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=96

Comments

Popular posts from this blog

In Situ Hybridization Market Growth Analysis - Global Forecast To 2021

According to the new market research report  " In situ Hybridization Market  by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region. North America is expected to account for the largest share of the global market. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, g

Interventional Oncology Market Latest Trends 2019

The interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019. The market is expected to grow at a CAGR of 6.8% from 2019 to 2024. The growth of this market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and the increasing government investments and funding for interventional oncology and related cancer research. The introduction of advanced interventional oncology products is a major technological advancement in the interventional oncology field. These advancements are largely related to the commercialization of more effective, simple, and easy-to-use products for interventional oncology procedures. Based on product, the interventional oncology market is segmented into ablation devices, embolization devices, an